GMED - Globus Medical, Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
51.76
-0.71 (-1.36%)
As of 2:51PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close52.47
Open52.30
Bid51.72 x 1200
Ask51.76 x 1000
Day's Range51.64 - 52.53
52 Week Range27.79 - 57.55
Volume260,645
Avg. Volume595,265
Market Cap5.085B
Beta1.08
PE Ratio (TTM)38.20
EPS (TTM)1.36
Earnings DateNov 6, 2018 - Nov 12, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est59.89
Trade prices are not sourced from all markets
  • GlobeNewswireyesterday

    New Research Coverage Highlights Arena Pharmaceuticals, Varian Medical, SS&C Technologies, Globus Medical, Zynga, and Diamondrock Hospitality — Consolidated Revenues, Company Growth, and Expectations for 2018

    NEW YORK, Aug. 14, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Arena ...

  • See what the IHS Markit Score report has to say about Globus Medical Inc.
    Markit13 days ago

    See what the IHS Markit Score report has to say about Globus Medical Inc.

    Short interest is low for GMED with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. The $1.22 billion in inflows that ETFs holding GMED received over the last one-month is a decline from earlier in the period and among the weakest of the past year.

  • Thomson Reuters StreetEvents14 days ago

    Edited Transcript of GMED earnings conference call or presentation 1-Aug-18 8:30pm GMT

    Q2 2018 Globus Medical Inc Earnings Call

  • Associated Press14 days ago

    Globus Medical: 2Q Earnings Snapshot

    The Audubon, Pennsylvania-based company said it had net income of 44 cents per share. The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research ...

  • GlobeNewswire14 days ago

    Globus Medical Reports Second Quarter 2018 Results

    AUDUBON, Pa., Aug. 01, 2018-- Globus Medical, Inc., a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended June 30, 2018.. Worldwide sales were ...

  • See what the IHS Markit Score report has to say about Globus Medical Inc.
    Markit15 days ago

    See what the IHS Markit Score report has to say about Globus Medical Inc.

    Short interest is low for GMED with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. The $1.18 billion in inflows that ETFs holding GMED received over the last one-month is a decline from earlier in the period and among the weakest of the past year.

  • Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report?
    Zacks19 days ago

    Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report?

    Globus Medical (GMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

  • How Zimmer Biomet’s Product Porfolio Is Positioned
    Market Realist21 days ago

    How Zimmer Biomet’s Product Porfolio Is Positioned

    In the first quarter of this year, Zimmer Biomet’s (ZBH) knee device revenue grew ~1.8% YoY (year-over-year) to $713.3 million from $700.8 million. In the Americas, EMEA (Europe, the Middle East, and Africa), and Asia-Pacific, the knee segment generated revenue of $417.2 million, $188.9 million, and $107.2 million, respectively, reflecting a ~2.5% decline, ~12.4% growth, and ~2.3% growth YoY from $428.0 million, $167.9 million, and $104.9 million.

  • GlobeNewswirelast month

    Globus Medical Schedules Second Quarter 2018 Earnings Release and Conference Call

    Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30, 2018 after the market close on Wednesday, August 1, 2018. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors. Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time.

  • GlobeNewswirelast month

    Globus Medical Features Latest Innovative Technologies at Scoliosis Research Society’s International Meeting on Advanced Spine Technologies

    Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, will showcase its advanced technologies at the Scoliosis Research Society’s (SRS) 25th Annual International Meeting on Advanced Spine Techniques (IMAST) being held July 11-14, 2018, in Los Angeles, California.  The company will also highlight its robotics platform technology through an industry workshop at IMAST, ExcelsiusGPS® First Clinical Experiences, featuring its revolutionary robotic guidance and navigation system on July 13 from 12:00-1:00 pm led by Dr. Jeffrey A. Goldstein, Chief of Spine Service for Education and Director of the Spine Fellowship at NYU Langone Orthopedic Hospital.

  • ACCESSWIRElast month

    Free Technical Reports on InspireMD and Three Additional Medical Equipment Equities

    LONDON, UK / ACCESSWIRE / July 10, 2018 / If you want a free Stock Review on NSPR sign up now at www.wallstequities.com/registration. Gains were broad based as eight out of nine sectors finished the trading session in green. WallStEquities.com has initiated research reports on the following Medical Appliances & Equipment stocks: Globus Medical Inc. (NYSE: GMED), InspireMD Inc. (NYSE AMER: NSPR), Lantheus Holdings Inc. (NASDAQ: LNTH), and LivaNova PLC (NASDAQ: LIVN).

  • GlobeNewswirelast month

    Globus Medical Adds Two Innovative Solutions to Growing Trauma Portfolio

    “This is an exciting time for Globus Trauma as we continue to execute our product launch strategy and build a comprehensive Trauma product portfolio,” said Barclay Davis, Vice President, Orthopedic Trauma.

  • GlobeNewswire2 months ago

    Globus Medical Announces ExcelsiusGPS® Milestone: 3,000 screws implanted

    Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, announced today a new clinical milestone with the successful implantation of over 3,000 screws using ExcelsiusGPS®,  the company’s revolutionary robotic guidance and navigation system. Since the launch of ExcelsiusGPS® in late 2017, orthopedic and neurosurgeons have used the system with three compatible imaging modalities (preoperative CT, intraoperative CT, and fluoroscopic imaging) across a variety of spine surgery procedures to minimize radiation exposure, streamline workflow, and assist in screw placement.  A recent white paper comparing robotic-assisted versus conventional screw placement demonstrates some of the benefits of this technology. “Having completed installations and surgeon training programs through the first half of 2018, we see surgeons using this technology in open and minimally invasive spine procedures including posterior cervical fusion, sacroiliac joint fusion, and thoracolumbar fusion with posterior and single position lateral approaches,” said Chief Executive Officer Dave Demski.

  • ITGR vs. GMED: Which Stock Is the Better Value Option?
    Zacks2 months ago

    ITGR vs. GMED: Which Stock Is the Better Value Option?

    ITGR vs. GMED: Which Stock Is the Better Value Option?

  • Why Globus Medical Inc (NYSE:GMED) Delivered An Inferior ROE Compared To The Industry
    Simply Wall St.2 months ago

    Why Globus Medical Inc (NYSE:GMED) Delivered An Inferior ROE Compared To The Industry

    The content of this article will benefit those of you who are starting to educate yourself about investing in the stock market and want to begin learning the link betweenRead More...

  • Globus Medical: What Contributed to Its Valuations?
    Market Realist2 months ago

    Globus Medical: What Contributed to Its Valuations?

    Globus Medical (GMED) has missed three consensus revenue estimates and one consensus EPS estimate in the last 20 quarters. It has a dividend yield of 0% compared to the sector and the S&P 500 at 0.9% and 2.3%, respectively. What contributed to GMED’s valuations?

  • 5 AI Biotech Stocks to Bet On Now
    InvestorPlace2 months ago

    5 AI Biotech Stocks to Bet On Now

    Biotech stocks are also capitalizing on AI’s potential to deliver revolutionary drugs and speed up drug discovery. “I believe that AI is a sleeping giant for healthcare in general,” Eric Horvitz, director of Microsoft Research Labs, said earlier this year.

  • GlobeNewswire2 months ago

    Globus Medical Launches Cement Augmented Pedicle Screw System

    Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, today announced the launch of the CREO® Fenestrated Screw System used in the treatment of patients with advanced stage tumors of the thoracolumbar spine. CREO® fenestrated screws, when augmented with the company’s FORTRESS™ radiopaque bone cement, are designed to restore the structural integrity of the spine at vertebral levels affected by metastatic bone disease.

  • As Spinal Stocks Climb Toward Yearly Highs, There’s Still Room for Upside
    InvestorPlace2 months ago

    As Spinal Stocks Climb Toward Yearly Highs, There’s Still Room for Upside

    Cantor Fitzgerald is starting coverage on biotech companies in the spinal segment, a market that the investment house thinks has a $9-billion global market opportunity. Globus Medical Inc (NYSE:GMED) earned an “Overweight” rating from Cantor Fitzgerald. GMED stock has a market cap of $5.41 billion and is valued at 10.6 times its book value per share.

  • ITGR vs. GMED: Which Stock Should Value Investors Buy Now?
    Zacks2 months ago

    ITGR vs. GMED: Which Stock Should Value Investors Buy Now?

    ITGR vs. GMED: Which Stock Is the Better Value Option?

  • ACCESSWIRE2 months ago

    Free Daily Technical Summary Reports on LivaNova and Three Other Medical Equipment Stocks

    WallStEquities.com monitors four Medical Appliances and Equipment stocks, namely: Globus Medical Inc. (NYSE: GMED), Inspire Medical Systems Inc. (NYSE: INSP), InspireMD Inc. (NYSE AMER: NSPR), and LivaNova PLC (NASDAQ: LIVN). Audubon, Pennsylvania headquartered Globus Medical Inc.'s shares recorded a trading volume of 636,640 shares last Friday.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of GMED earnings conference call or presentation 2-May-18 8:30pm GMT

    Q1 2018 Globus Medical Inc Earnings Call

  • Benzinga2 months ago

    Cantor Fitzgerald Taps Spinal Stocks: 4 Top Picks

    Spine stocks were steadied with supportive coverage from the Street this week.  The Ratings Cantor Fitzgerald analysts Craig Bijou and Jordan Abrams initiated coverage on: Globus Medical Inc (NYSE: GMED ...

  • GlobeNewswire3 months ago

    Globus Medical Announces Appointment of Orthopedic Trauma Division’s Vice President of Sales

    AUDUBON, Pa., May 21, 2018-- Globus Medical, Inc., a leading musculoskeletal solutions company, today announced the appointment of Daniel Gregoris to Vice President of Sales for the company’ s emerging ...